These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8971280)

  • 41. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral methotrexate therapy: pro and con].
    Zachariae H
    Hautarzt; 1985 Jan; 36(1):10-2. PubMed ID: 3972575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Hall PD; Ahern MJ; Jarvis LR; Stoll P; Jenner MA; Harley H
    Ann Rheum Dis; 1991 Jul; 50(7):471-6. PubMed ID: 1877853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate and liver biopsies. Is it really necessary?
    Roenigk HH
    Arch Intern Med; 1990 Apr; 150(4):733-4. PubMed ID: 2327835
    [No Abstract]   [Full Text] [Related]  

  • 45. Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines.
    Tugwell P; Bennett K; Bell M; Gent M
    Ann Intern Med; 1989 Apr; 110(8):581-3. PubMed ID: 2648921
    [No Abstract]   [Full Text] [Related]  

  • 46. Busting the myth of methotrexate chronic hepatotoxicity.
    Di Martino V; Verhoeven DW; Verhoeven F; Aubin F; Avouac J; Vuitton L; Lioté F; Thévenot T; Wendling D
    Nat Rev Rheumatol; 2023 Feb; 19(2):96-110. PubMed ID: 36564450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis.
    Schwartz GF; Anderson ST
    J Rheumatol; 1990 Jul; 17(7):980. PubMed ID: 2213769
    [No Abstract]   [Full Text] [Related]  

  • 49. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
    Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C;
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC; Menter MA
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract]   [Full Text] [Related]  

  • 51. Liver injury associated with methotrexate therapy for psoriasis.
    Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
    Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
    [No Abstract]   [Full Text] [Related]  

  • 52. Methotrexate: the emerging drug of choice for serious rheumatoid arthritis.
    Salach RH; Cash JM
    Clin Ther; 1994; 16(6):912-22; discussion 911. PubMed ID: 7697687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methotrexate hepatotoxicity: what is the evidence?
    Ahern MJ; Smith MD; Roberts-Thomson PJ
    Inflamm Res; 1998 Apr; 47(4):148-51. PubMed ID: 9628257
    [No Abstract]   [Full Text] [Related]  

  • 55. A review of methotrexate-associated hepatotoxicity.
    Bath RK; Brar NK; Forouhar FA; Wu GY
    J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACP Journal Club. Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD.
    Smith MD
    Ann Intern Med; 2015 Jul; 163(2):JC7. PubMed ID: 26192587
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.
    Dávila-Fajardo CL; Swen JJ; Cabeza Barrera J; Guchelaar HJ
    Pharmacogenomics; 2013 Jan; 14(1):63-73. PubMed ID: 23252949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver disease, erroneously attributed to methotrexate, in a patient with rheumatoid arthritis.
    Bills LJ; Seibert D; Brick JE
    J Rheumatol; 1992 Dec; 19(12):1963-5. PubMed ID: 1294748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Methotrexate in rheumatic practice].
    Jacquemier JM; Pages M; Lassoued S
    Ann Med Interne (Paris); 1989; 140(3):192-6. PubMed ID: 2669600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.